Mumbai, May 19 -- The scrip was listed at Rs 59.75, a 38.95% premium to the initial public offer (IPO) price. The stock is currently frozen at its lower limit of 5% over its listing price.

The counter hit a high of Rs 60 and a low of Rs 56.77. About 9.72 lakh shares of the company changed hands at the counter.

Goldline Pharmaceutical's IPO was subscribed 781.85 times. The issue opened for bidding on 12 May 2026 and it closed on 14 May 2026. The price band of the IPO was fixed between Rs 41 to Rs 43 per share.

The IPO comprised 27,00,000 equity shares. The company intends to utilise the net proceeds for repayment of all or a portion of certain outstanding borrowings availed by the company and general corporate purposes.

Ahead of the IP...